CJC-1295: DAC, no DAC and blends
CJC-1295 with DAC, the material commonly sold as CJC-1295 no DAC, and ipamorelin are different entries to check. A vial combining no-DAC material with ipamorelin is also a different product from either ingredient alone. The letters on the label matter.
DAC refers to the modification used in the longer-acting CJC-1295 studied in the cited work. The comparison below separates that material from no-DAC naming and from ipamorelin. It explains identity and evidence, not a personal-use schedule or a recommendation to combine products.
Which CJC-1295 listing is standalone, and which includes Ipamorelin?
Search results for CJC-1295, no DAC or Ipamorelin can lead to a blend. Check the ingredient list before comparing prices: the blend is not a substitute for a single-component listing.
| Listing | What the name describes | Check before comparing |
|---|---|---|
| CJC-1295 with DAC | The DAC form, without an Ipamorelin blend in the listing name. | Exact specification and current availability. |
| CJC-1295 no DAC | The standalone no-DAC catalogue entry. | Its own status and report; do not transfer a blend result. |
| Ipamorelin | A separate compound, not another name for CJC-1295. | Its own labelled amount and current price, if announced. |
| CJC no DAC + Ipamorelin 10mg | A two-ingredient blend. | The total label amount versus each component and the applicable batch report. |
A search for cheap Ipamorelin does not make the blend’s total price per mg an Ipamorelin-only price. Compare like ingredients and amounts. Where a listing says Coming soon, the notification bell records interest; it does not reserve stock or confirm a release date.
What do with DAC, no DAC and ipamorelin mean?
| Term | What to establish | Common mistake |
|---|---|---|
| CJC-1295 with DAC | The specified albumin-binding GHRH analog | Applying its persistence data to a no-DAC material |
| CJC-1295 no DAC / Mod GRF 1-29 | Exact peptide sequence and terminal modifications in the supplier specification | Treating the shared CJC name as proof of the same compound |
| Ipamorelin | The separate peptide and its identity results | Assuming it is another name for CJC-1295 |
| No-DAC CJC + ipamorelin blend | Both identities and the amount of each component | Interpreting the total vial quantity as the quantity of each ingredient |
Which form did the CJC-1295 studies actually test?
Jetté and colleagues investigated an albumin-binding GRF analog using cell assays and animal experiments. Their work linked the modification to longer persistence of the studied compound. The finding concerns a specified chemical design, not every product that later acquired a similar catalogue name. Jetté et al., 2005.
Is ipamorelin another name for CJC-1295?
The original pharmacology study described ipamorelin as a pentapeptide and examined growth-hormone release in rat pituitary cells and animal models. That is evidence about a distinct molecule and experimental setting. It does not validate a finished two-peptide mixture or establish a general human outcome from that mixture. Raun et al., 1998.
For literature review, record which molecule was tested, whether the work used cells, animals or people, the formulation, and the measured endpoint. A familiar receptor pathway is not enough to make two materials equivalent.
What should the label and lab report make clear?
- Is the requested material a single peptide or a blend?
- What sequence and terminal modifications identify the CJC component?
- Is an albumin-binding modification specified?
- Does the report identify each blend component and state its amount where measured?
- Does the batch identifier match the supplied material?
The COA verification guide explains how to record those answers. Price and availability belong to the exact product listing, not to a loosely related keyword.
Does a longer half-life mean one product is better?
No. A duration measured for a particular compound and study does not establish an overall benefit or make another material interchangeable. Keep the tested identity, study setting and outcome together when reading comparisons.
EPS documentation
Use the research catalogue to check the exact name, labelled amount and format. The COA library publishes the original Janoshik reports selected for EPS, retaining the original report client name and any missing batch fields. Literature findings and another supplier's analytical results are not evidence about an EPS batch.
